The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Links

 

Gene Review

EIF3M  -  eukaryotic translation initiation factor 3...

Bos taurus

 
 
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.
 

Disease relevance of HFL-B5

 

High impact information on HFL-B5

  • The data establish a critical role for self-antigen in DC activation and explain how the innate immune system might drive the adaptive immune response in SLE [1].
  • A greatly enhanced capacity to stimulate T-lymphocyte alloproliferation and increased expression of the DC-associated transcription factor RelB were observed [2].
  • Under serum-free conditions, this resulted in differentiation of a majority of cells toward a DC phenotype within 36 to 48 hours, without the need for cytokine-induced predifferentiation [2].
  • Long-term culture of human CD34(+) progenitors with FLT3-ligand, thrombopoietin, and stem cell factor induces extensive amplification of a CD34(-)CD14(-) and a CD34(-)CD14(+) dendritic cell precursor [6].
  • Using double immunofluorescence, these deposits co-localize with HLA-DR and S-100 immunoreactive cells in the intima, which are components of the vascular-associated dendritic cell network, as well as with HLA-DR and CD-68 immunopositive macrophages of the intima and media [7].
 

Biological context of HFL-B5

  • In addition, we detected GAD65 peptide-specific IgG1 antibody responses in DC-treated mice [8].
  • The basis for this study was the "injury hypothesis," which holds that release of micro-environmental constituents, such as reactive oxygen species and oxidants, acts as a signal, and potential activator, of dendritic cell (DC)-mediated antigen presentation [9].
  • Thus, AOPP may act like superantigens, allowing for bypass of upregulation of costimulation, and, either alone or in synergy with oxidants themselves, serving as amplifiers of DC function [9].
  • This requirement is, in part, a result of poor vaccine spreading and suboptimal DC transfection efficiency [10].
  • Keywords: DC vaccines/dendritic cell development/fetal calf serum-free culture conditions for DC/in vivo therapeutic DC approaches [11].
 

Anatomical context of HFL-B5

 

Other interactions of HFL-B5

 

Analytical, diagnostic and therapeutic context of HFL-B5

  • The two DC populations migrated to the spleen and pancreas after intravenous injection [8].
  • CONCLUSION: It's possible to obtain DC from autotransfusion of patients with pancreatic carcinoma: these cells do not show evident quantitative or qualitative alterations, are able to present soluble antigen even when cultured in the presence of human serum and may be used in immunological tumour treatments [19].
  • Optimizing follicular dendritic cell isolation by discontinuous gradient centrifugation and use of the magnetic cell sorter (MACS) [20].

References

  1. Toll-like receptor 9-dependent and -independent dendritic cell activation by chromatin-immunoglobulin G complexes. Boulé, M.W., Broughton, C., Mackay, F., Akira, S., Marshak-Rothstein, A., Rifkin, I.R. J. Exp. Med. (2004) [Pubmed]
  2. Adenovirus type 5 vectors induce dendritic cell differentiation in human CD14(+) monocytes cultured under serum-free conditions. Lyakh, L.A., Koski, G.K., Young, H.A., Spence, S.E., Cohen, P.A., Rice, N.R. Blood (2002) [Pubmed]
  3. Lactoferrin prevents dendritic cell-mediated human immunodeficiency virus type 1 transmission by blocking the DC-SIGN--gp120 interaction. Groot, F., Geijtenbeek, T.B., Sanders, R.W., Baldwin, C.E., Sanchez-Hernandez, M., Floris, R., van Kooyk, Y., de Jong, E.C., Berkhout, B. J. Virol. (2005) [Pubmed]
  4. Mycobacterium bovis Bacillus Calmette-Guerin infects DC-SIGN- dendritic cell and causes the inhibition of IL-12 and the enhancement of IL-10 production. Gagliardi, M.C., Teloni, R., Giannoni, F., Pardini, M., Sargentini, V., Brunori, L., Fattorini, L., Nisini, R. J. Leukoc. Biol. (2005) [Pubmed]
  5. Modulation of dendritic cell differentiation and cytokine secretion by the hydatid cyst fluid of Echinococcus granulosus. Kanan, J.H., Chain, B.M. Immunology (2006) [Pubmed]
  6. Long-term culture of human CD34(+) progenitors with FLT3-ligand, thrombopoietin, and stem cell factor induces extensive amplification of a CD34(-)CD14(-) and a CD34(-)CD14(+) dendritic cell precursor. Arrighi, J.F., Hauser, C., Chapuis, B., Zubler, R.H., Kindler, V. Blood (1999) [Pubmed]
  7. Disease-associated prion protein in vessel walls. Koperek, O., Kovács, G.G., Ritchie, D., Ironside, J.W., Budka, H., Wick, G. Am. J. Pathol. (2002) [Pubmed]
  8. Immunotherapy of NOD mice with bone marrow-derived dendritic cells. Feili-Hariri, M., Dong, X., Alber, S.M., Watkins, S.C., Salter, R.D., Morel, P.A. Diabetes (1999) [Pubmed]
  9. The role of advanced oxidation protein products in regulation of dendritic cell function. Alderman, C.J., Shah, S., Foreman, J.C., Chain, B.M., Katz, D.R. Free Radic. Biol. Med. (2002) [Pubmed]
  10. Enhancement of antigen acquisition by dendritic cells and MHC class II-restricted epitope presentation to CD4+ T cells using VP22 DNA vaccine vectors that promote intercellular spreading following initial transfection. Mwangi, W., Brown, W.C., Splitter, G.A., Zhuang, Y., Kegerreis, K., Palmer, G.H. J. Leukoc. Biol. (2005) [Pubmed]
  11. Fetal calf serum-free generation of functionally active murine dendritic cells suitable for in vivo therapeutic approaches. Müller, G., Müller, A., Jonuleit, H., Steinbrink, K., Szalma, C., Paragnik, L., Lingnau, K., Schmidt, E., Knop, J., Enk, A.H. J. Invest. Dermatol. (2000) [Pubmed]
  12. DNA-encoded fetal liver tyrosine kinase 3 ligand and granulocyte macrophage-colony-stimulating factor increase dendritic cell recruitment to the inoculation site and enhance antigen-specific CD4+ T cell responses induced by DNA vaccination of outbred animals. Mwangi, W., Brown, W.C., Lewin, H.A., Howard, C.J., Hope, J.C., Baszler, T.V., Caplazi, P., Abbott, J., Palmer, G.H. J. Immunol. (2002) [Pubmed]
  13. Trichomonas vaginalis Lipophosphoglycan Triggers a Selective Upregulation of Cytokines by Human Female Reproductive Tract Epithelial Cells. Fichorova, R.N., Trifonova, R.T., Gilbert, R.O., Costello, C.E., Hayes, G.R., Lucas, J.J., Singh, B.N. Infect. Immun. (2006) [Pubmed]
  14. Distribution of cells immunopositive for AM-3K, a novel monoclonal antibody recognizing human macrophages, in normal and diseased tissues of dogs, cats, horses, cattle, pigs, and rabbits. Yamate, J., Yoshida, H., Tsukamoto, Y., Ide, M., Kuwamura, M., Ohashi, F., Miyamoto, T., Kotani, T., Sakuma, S., Takeya, M. Vet. Pathol. (2000) [Pubmed]
  15. Isolation and characterisation of equine dendritic cells. Siedek, E., Little, S., Mayall, S., Edington, N., Hamblin, A. Vet. Immunol. Immunopathol. (1997) [Pubmed]
  16. Characterization of bovine cDNA encoding triggering receptor expressed on myeloid cells 1 (TREM-1). Ramanathan, B., Minton, J.E., Ross, C.R., Blecha, F. Vet. Immunol. Immunopathol. (2004) [Pubmed]
  17. Molecular characterization of coding sequences and analysis of Toll-like receptor 3 mRNA expression in water buffalo (Bubalus bubalis) and nilgai (Boselaphus tragocamelus). Dhara, A., Saini, M., Das, D.K., Swarup, D., Sharma, B., Kumar, S., Gupta, P.K. Immunogenetics (2007) [Pubmed]
  18. Mycobacterium paratuberculosis heat shock protein 70 as a tool in control of paratuberculosis. Langelaar, M., Koets, A., Müller, K., van Eden, W., Noordhuizen, J., Howard, C., Hope, J., Rutten, V. Vet. Immunol. Immunopathol. (2002) [Pubmed]
  19. Generation and functional characterisation of dendritic cells from patients with pancreatic carcinoma with special regard to clinical applicability. Piemonti, L., Monti, P., Zerbi, A., Balzano, G., Allavena, P., Di Carlo, V. Cancer Immunol. Immunother. (2000) [Pubmed]
  20. Optimizing follicular dendritic cell isolation by discontinuous gradient centrifugation and use of the magnetic cell sorter (MACS). Schmitz, J., Petrasch, S., van Lunzen, J., Racz, P., Kleine, H.D., Hufert, F., Kern, P., Schmitz, H., Tenner-Racz, K. J. Immunol. Methods (1993) [Pubmed]
 
WikiGenes - Universities